SurModics Total Revenue Over Time

SRDX Stock  USD 40.03  0.09  0.23%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out SurModics Performance and SurModics Correlation.
For more information on how to buy SurModics Stock please use our How to Invest in SurModics guide.
  
Total Revenue is likely to drop to about 75.8 M in 2024.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SurModics. If investors know SurModics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SurModics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.358
Earnings Share
(0.82)
Revenue Per Share
8.908
Quarterly Revenue Growth
0.188
Return On Assets
(0.01)
The market value of SurModics is measured differently than its book value, which is the value of SurModics that is recorded on the company's balance sheet. Investors also form their own opinion of SurModics' value that differs from its market value or its book value, called intrinsic value, which is SurModics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SurModics' market value can be influenced by many factors that don't directly affect SurModics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SurModics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SurModics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SurModics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Total Revenue Analysis

Compare SurModics and related stocks such as ProSomnus, Common Stock, LivaNova PLC, and Electromed Total Revenue Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
LIVN100 K218.5 M254.3 M282 M291.6 M415.7 M1.2 BB1.1 B1.1 B934.2 MBB1.2 B1.2 B
ELMD8.8 M19.5 M15.1 M15.5 M19.4 M23 M25.9 M28.7 M31.3 M32.5 M35.8 M41.7 M48.1 M54.7 M28.9 M
KIDS23.7 M23.7 M23.7 M23.7 M23.7 M31 M37.3 M45.6 M57.6 M72.6 M71.1 M98 M122.3 M148.7 M77.9 M
NPCE37 M37 M37 M37 M37 M37 M37 M37 M37 M37 M41.1 M45.2 M45.5 M65.4 M51.5 M
INGN30.6 M30.6 M48.6 M75.4 M112.5 M159 M202.8 M249.4 M358.1 M361.9 M308.5 M358 M377.2 M315.7 M250.3 M
LUNG115 K115 K115 K115 K332 K19.4 K8.8 K0.020 M32.6 M32.7 M48.4 M53.7 M68.7 M72.1 M
APYX5.5 M25.4 M27.7 M23.7 M27.7 M29.5 M36.6 M38.9 M16.7 M28.2 M27.7 M48.5 M44.5 M52.3 M26.2 M
CNMD10.5 M725.1 M767.1 M756.8 M734.5 M719.2 M763.5 M796.4 M859.6 M955.1 M862.5 MBB1.2 B1.3 B
SIBN37 M37 M37 M49 M40.1 M41.2 M42.1 M48 M55.4 M67.3 M73.4 M90.2 M106.4 M138.9 M72.3 M
AXGN4.7 M4.8 M7.7 M10.9 M16.8 M27.3 M41.1 M60.4 M83.9 M106.7 M112.3 M127.4 M138.6 M159 M167 M
ANIK2.2 M64.8 M71.4 M75.1 M105.6 M93 M103.4 M113.4 M105.6 M114.6 M130.5 M147.8 M156.2 M166.7 M175 M
OFIX20.9 M579 M462.3 M400.5 M402.3 M396.5 M409.8 M433.8 M453 M460 M406.6 M464.5 M460.7 M746.6 M784 M
FNA106.3 M106.3 M106.3 M106.3 M106.3 M106.3 M106.3 M106.3 M106.3 M106.3 M111 M147.5 M181.4 M216.4 M167.7 M
ITGR79.2 M568.8 M646.2 M663.9 M687.8 M800.4 M1.4 B1.5 B1.2 B1.3 B1.1 B1.2 B1.4 B1.6 B1.7 B
SGHT7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M23.3 M27.6 M49 M71.3 M81.1 M47.6 M

SurModics and related stocks such as ProSomnus, Common Stock, LivaNova PLC, and Electromed Total Revenue description

Total revenue comprises all receipts SurModics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

My Equities

My Current Equities and Potential Positions

SurModics
SRDX
Specialization
Health Care, Health Care Equipment & Services
LocationMinnesota; U.S.A
ExchangeNASDAQ Exchange
USD 40.03

Additional Tools for SurModics Stock Analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.